COX-2: a molecular target for colorectal cancer prevention

Joanne R Brown1, Raymond N DuBois

  • 1The Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA.

Insights

Nonsteroidal anti-inflammatory drugs (NSAIDs) show protective effects against colorectal cancers (CRCs). Specifically, cyclooxygenase-2 (COX-2) inhibitors are being evaluated for broader use due to their role in cancer progression.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Cyclooxygenase (COX) is a key enzyme in prostanoid biosynthesis and is implicated in human cancers.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs), which inhibit COX activity, have demonstrated protective effects against colorectal cancers (CRCs).
  • The inducible COX-2 isoform is overexpressed in CRC tissues, correlating with a poor prognosis.

Purpose of the Study:

  • To investigate the role of cyclooxygenase (COX) enzymes, particularly COX-2, in the development and progression of colorectal cancers (CRCs).
  • To evaluate the therapeutic potential of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors in CRC prevention and treatment.

Main Methods:

  • Review of observational and randomized controlled studies on NSAIDs and CRC.
  • Analysis of experimental studies elucidating the mechanisms of COX-2 in carcinogenesis.
  • Examination of clinical trial data for selective COX-2 inhibitors in familial polyposis and broader populations.

Main Results:

  • Numerous studies confirm the protective effects of NSAIDs against CRC development.
  • Overexpression of COX-2 in CRC tissues is a significant negative prognostic indicator.
  • Experimental evidence highlights COX-2's crucial role in cancer-related pathways.

Conclusions:

  • NSAIDs, particularly COX-2 inhibitors, hold significant promise for colorectal cancer prevention and treatment.
  • Selective COX-2 inhibitors are approved for familial polyposis and are under investigation for wider clinical application.
  • Targeting COX-2 represents a viable strategy in the ongoing fight against colorectal cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...